Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.36233/0507-4088-2020-65-3-167-175 http://scihub22266oqcxt.onion/10.36233/0507-4088-2020-65-3-167-175 33533219!ä!33533219 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538 Warning: Undefined variable $yww in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 538       Vopr+Virusol 2020 ; 65 (3): 167-175 Nephropedia Template TP {{tp|p=33533219|t=2020. The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis |pdf=|usr=}}{{33533219}} gab.com Text The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis JO: Vopr Virusol http://www.kidney.de/pget.php?&tw=1&pmid=33533219 #FOAvip This review article considers the possibilities of combined antiviral therapy in the treatment of patients with COVID-19, based on the analysis of the mechanism of action of known antiviral drugs in the framework of the medical hypothesis. The potential effectiveness of the joint use of viral RNA polymerase inhibitors and a fusion inhibitor in this pathology is discussed. The review discusses the main representatives of these groups of drugs - ribavirin, riamilovir, umifenovir, favipiravir. The efficacy and safety profile of these drugs was analyzed, including the experience of their use in clinical trials conducted during the COVID-19 pandemic, as well as earlier work performed during the SARS and MERS epidemics. Twit Text FOAVip The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis ????Vopr Virusol http://www.kidney.de/pget.php?&tw=1&pmid=33533219 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33533219 #FOAvip English Wikipedia <ref>{{Cite pmid|33533219}}</ref> The use of viral RNA polymerase inhibitors in combination with a fusion inhibitor in the treatment of patients with COVID-19: hypothesis #MMPMID33533219 Gaisenok OV Vopr Virusol 2020[Jul]; 65 (3): 167-175 PMID33533219show ga This review article considers the possibilities of combined antiviral therapy in the treatment of patients with COVID-19, based on the analysis of the mechanism of action of known antiviral drugs in the framework of the medical hypothesis. The potential effectiveness of the joint use of viral RNA polymerase inhibitors and a fusion inhibitor in this pathology is discussed. The review discusses the main representatives of these groups of drugs - ribavirin, riamilovir, umifenovir, favipiravir. The efficacy and safety profile of these drugs was analyzed, including the experience of their use in clinical trials conducted during the COVID-19 pandemic, as well as earlier work performed during the SARS and MERS epidemics. |*COVID-19 Drug Treatment[MESH] |*COVID-19/epidemiology[MESH] |*Pandemics[MESH] |Antiviral Agents/*therapeutic use[MESH] |Enzyme Inhibitors/*therapeutic use[MESH] |Humans[MESH] |RNA-Dependent RNA Polymerase/*antagonists & inhibitors/metabolism[MESH] The use of viral RNA polymerase inhibitors in combination with a fusi(epmc).pdf DeepDyve Pubget Overpricing